HIGHLIGHTS
- who: January and collaborators from the University of Singapore, Singapore TotiCell Limited, Bangladesh have published the research: Mesenchymal stem cell-based therapy for female stress urinary incontinence, in the Journal: (JOURNAL)
- what: Five women showed an objective improvement of >50% (p and amp;lt;.05) and a subjective improvement of 70%-80% from baseline ASC therapy is a feasible and safe therapy for the treatment of urinary incontinence in men and women Two prospective, non-randomized phases I-II a clinical trials have reported that stem_cell-based SUI therapy provides acceptable functional results with minimal . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.